{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T11:12:24Z","timestamp":1767093144563,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Kinderkrebshilfe Tirol und Vorarlberg"},{"name":"Kinderkrebshilfe S\u00fcdtirol-Regenbogen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s40121-021-00427-5","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T16:02:52Z","timestamp":1615478572000},"page":"789-800","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Which Type of Empiric Antibiotic Therapy is Appropriate? A 20-Year Retrospective Study of Bloodstream Infections in Childhood Cancer"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7749-5334","authenticated-orcid":false,"given":"Andreas","family":"Meryk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Kropshofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bargehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Hetzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Lass-Fl\u00f6rl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4336-6275","authenticated-orcid":false,"given":"Roman","family":"Crazzolara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,11]]},"reference":[{"issue":"2","key":"427_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3322\/caac.21219","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103.","journal-title":"CA Cancer J Clin"},{"doi-asserted-by":"crossref","unstructured":"Meryk A, Kropshofer G, Hutter J, et al. Benefits of risk-adapted and mould-specific antifungal prophylaxis in childhood leukaemia. Br J Haematol. 2020;191(5):816\u201324.","key":"427_CR2","DOI":"10.1111\/bjh.16931"},{"issue":"7","key":"427_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2014-03-560847","volume":"124","author":"D O'Connor","year":"2014","unstructured":"O\u2019Connor D, Bate J, Wade R, et al. Infection-related mortality in children with acute lymphoblastic leukemia: an analysis of infectious deaths on UKALL2003. Blood. 2014;124(7):1056\u201361.","journal-title":"Blood"},{"issue":"1","key":"427_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2141.2005.05736.x","volume":"131","author":"MS Christensen","year":"2005","unstructured":"Christensen MS, Heyman M, Mottonen M, et al. Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992\u20132001. Br J Haematol. 2005;131(1):50\u20138.","journal-title":"Br J Haematol"},{"issue":"1","key":"427_CR5","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/sj.leu.2403188","volume":"18","author":"T Lehrnbecher","year":"2004","unstructured":"Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia. 2004;18(1):72\u20137.","journal-title":"Leukemia"},{"key":"427_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fped.2019.00260","volume":"7","author":"O Beck","year":"2019","unstructured":"Beck O, Muensterer O, Hofmann S, et al. Central venous access devices (CVAD) in pediatric oncology patients-a single-center retrospective study over more than 9 years. Front Pediatr. 2019;7:260.","journal-title":"Front Pediatr"},{"issue":"5","key":"427_CR7","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1542\/peds.2015-1507","volume":"136","author":"AJ Ullman","year":"2015","unstructured":"Ullman AJ, Marsh N, Mihala G, Cooke M, Rickard CM. Complications of central venous access devices: a systematic review. Pediatrics. 2015;136(5):e1331\u201344.","journal-title":"Pediatrics"},{"issue":"4","key":"427_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/jac\/dkt477","volume":"69","author":"C Slimings","year":"2014","unstructured":"Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(4):881\u201391.","journal-title":"J Antimicrob Chemother"},{"key":"427_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2334-14-13","volume":"14","author":"BG Bell","year":"2014","unstructured":"Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.","journal-title":"BMC Infect Dis"},{"issue":"10","key":"427_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamapediatrics.2013.196","volume":"167","author":"PD Tamma","year":"2013","unstructured":"Tamma PD, Turnbull AE, Harris AD, Milstone AM, Hsu AJ, Cosgrove SE. Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients. JAMA Pediatr. 2013;167(10):903\u201310.","journal-title":"JAMA Pediatr"},{"issue":"5","key":"427_CR11","first-page":"666","volume":"64","author":"DA Hammond","year":"2017","unstructured":"Hammond DA, Smith MN, Li C, Hayes SM, Lusardi K, Bookstaver PB. Systematic review and meta-analysis of acute kidney injury associated with concomitant vancomycin and piperacillin\/tazobactam. Clin Infect Dis. 2017;64(5):666\u201374.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"427_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/PCC.0000000000002197","volume":"21","author":"SL Weiss","year":"2020","unstructured":"Weiss SL, Peters MJ, Alhazzani W, et al. Executive summary: Surviving Sepsis Campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Pediatr Crit Care Med. 2020;21(2):186\u201395.","journal-title":"Pediatr Crit Care Med"},{"issue":"7","key":"427_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","volume":"17","author":"B Gutierrez-Gutierrez","year":"2017","unstructured":"Gutierrez-Gutierrez B, Salamanca E, de Cueto M, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017;17(7):726\u201334.","journal-title":"Lancet Infect Dis"},{"issue":"23","key":"427_CR14","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa1703058","volume":"376","author":"CW Seymour","year":"2017","unstructured":"Seymour CW, Gesten F, Prescott HC, et al. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235\u201344.","journal-title":"N Engl J Med"},{"issue":"8","key":"427_CR15","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1097\/CCM.0000000000000330","volume":"42","author":"R Ferrer","year":"2014","unstructured":"Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749\u201355.","journal-title":"Crit Care Med"},{"issue":"9","key":"427_CR16","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","volume":"38","author":"A Kumar","year":"2010","unstructured":"Kumar A, Zarychanski R, Light B, et al. Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med. 2010;38(9):1773\u201385.","journal-title":"Crit Care Med"},{"doi-asserted-by":"crossref","unstructured":"Kadri SS, Lai YL, Warner S, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021;21(2):241\u201351.","key":"427_CR17","DOI":"10.1016\/S1473-3099(20)30477-1"},{"issue":"1","key":"427_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12879-017-2233-z","volume":"17","author":"KO Gradel","year":"2017","unstructured":"Gradel KO, Jensen US, Schonheyder HC, et al. Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study. BMC Infect Dis. 2017;17(1):122.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"427_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<336::AID-MPO5>3.0.CO;2-4","volume":"32","author":"G Wehl","year":"1999","unstructured":"Wehl G, Allerberger F, Heitger A, Meister B, Maurer K, Fink FM. Trends in infection morbidity in a pediatric oncology ward, 1986\u20131995. Med Pediatr Oncol. 1999;32(5):336\u201343.","journal-title":"Med Pediatr Oncol"},{"issue":"1","key":"427_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1\u201345.","journal-title":"Clin Infect Dis"},{"unstructured":"Isenberg HD. Clinical microbiology procedures handbook, vol. 1, sect. 5. Antimicrobial Susceptibility Testing. Washington, D.C.: American Society for Microbiology; 1992, pp. 5.0.1\u20135.25.1.","key":"427_CR21"},{"issue":"12","key":"427_CR22","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","volume":"98","author":"D Averbuch","year":"2013","unstructured":"Averbuch D, Orasch C, Cordonnier C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica. 2013;98(12):1826\u201335.","journal-title":"Haematologica"},{"issue":"18","key":"427_CR23","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","volume":"35","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082\u201394.","journal-title":"J Clin Oncol"},{"issue":"4","key":"427_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/bjh.13816","volume":"172","author":"O Blennow","year":"2016","unstructured":"Blennow O, Ljungman P. The challenge of antibiotic resistance in haematology patients. Br J Haematol. 2016;172(4):497\u2013511.","journal-title":"Br J Haematol"},{"issue":"Suppl 5","key":"427_CR25","doi-asserted-by":"publisher","first-page":"S331","DOI":"10.1093\/cid\/ciu598","volume":"59","author":"T Holland","year":"2014","unstructured":"Holland T, Fowler VG Jr, Shelburne SA 3rd. Invasive gram-positive bacterial infection in cancer patients. Clin Infect Dis. 2014;59(Suppl 5):S331\u20134.","journal-title":"Clin Infect Dis"},{"doi-asserted-by":"crossref","unstructured":"Routsi C, Gkoufa A, Arvaniti K, et al. De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shock. J Antimicrob Chemother. 2020;75:3665\u201374.","key":"427_CR26","DOI":"10.1093\/jac\/dkaa375"},{"issue":"1","key":"427_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00134-013-3148-9","volume":"40","author":"D Mokart","year":"2014","unstructured":"Mokart D, Slehofer G, Lambert J, et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med. 2014;40(1):41\u20139.","journal-title":"Intensive Care Med"},{"issue":"4","key":"427_CR28","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1128\/AAC.02166-13","volume":"58","author":"GL Daikos","year":"2014","unstructured":"Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother. 2014;58(4):2322\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"427_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jpeds.2013.01.062","volume":"163","author":"P de Blank","year":"2013","unstructured":"de Blank P, Zaoutis T, Fisher B, Troxel A, Kim J, Aplenc R. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr. 2013;163(3):699-705.e1.","journal-title":"J Pediatr"},{"issue":"5","key":"427_CR30","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.jpeds.2014.06.062","volume":"165","author":"CM Nylund","year":"2014","unstructured":"Nylund CM, Eide M, Gorman GH. Association of Clostridium difficile infections with acid suppression medications in children. J Pediatr. 2014;165(5):979-984.e1.","journal-title":"J Pediatr"},{"issue":"4","key":"427_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jpids\/piu008","volume":"3","author":"BT Fisher","year":"2014","unstructured":"Fisher BT, Sammons JS, Li Y, de Blank P, et al. Variation in risk of hospital-onset clostridium difficile infection across beta-lactam antibiotics in children with new-onset acute lymphoblastic leukemia. J Pediatric Infect Dis Soc. 2014;3(4):329\u201335.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"427_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2016.03.008","volume":"48","author":"KZ Vardakas","year":"2016","unstructured":"Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016;48(1):1\u201310.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"427_CR33","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1128\/AAC.02176-12","volume":"57","author":"KA Brown","year":"2013","unstructured":"Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326\u201332.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00427-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-021-00427-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-021-00427-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T19:21:13Z","timestamp":1620847273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-021-00427-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1007\/s40121-021-00427-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"type":"print","value":"2193-8229"},{"type":"electronic","value":"2193-6382"}],"subject":[],"published":{"date-parts":[[2021,3,11]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}